No profile data available.
Labcorp Holdings Inc. (LH) is a healthcare company in the medical testing laboratories industry, based in Burlington, United States, with about 70,000 full-time employees.
It reported revenue of $13.95 billion for fiscal year 2025, and net income of $876.50 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $3.73 billion. Its largest business segment, Diagnostics Laboratories, brought in 78% of segment revenue in fiscal year 2025. Its market capitalization was $21.73 billion as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of December 4, 2025.
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services.
Labcorp reported $13.95 billion in revenue for fiscal year 2025. In Q2 2026 revenue was $3.73 billion.
Diagnostics Laboratories, with $10.88 billion or 78% of segment revenue in fiscal year 2025. Next: Biopharma Laboratory Services (22%).
$21.73 billion as of December 4, 2025.
Listed companies of a similar size in the same industry (medical testing laboratories) include Quest Diagnostics Incorporated (DGX), NeoGenomics, Inc. (NEO), GeneDx Holdings Corp. (WGS), Opko Health, Inc. (OPK).